In Vertigo Emidas Tablet improves blood flow to the inner ear which reduces the pressure of excess fluid there. It is this pressure which is thought to cause the symptoms of nausea, vertigo (dizziness), tinnitus (ringing in your ears) and hearing loss in people who have Ménière’s disease. This medicine makes the symptoms milder and reduces the number of times you get the symptoms. It will be more effective if you take this medicine regularly as prescribed so try not to miss doses. It may take a couple of weeks before you notice any improvements but keep taking it, even if you do feel better, until your doctor advises it is safe to stop.
It is not known whether it is safe to consume alcohol with Emidas Tablet. Please consult your doctor.
Information regarding the use of Emidas Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Emidas Tablet during breastfeeding is not available. Please consult your doctor.
Emidas Tablet may cause side effects which could affect your ability to drive. Emidas Tablet may cause drowsiness and shakiness. This may affect your driving ability.
Emidas Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Emidas Tablet may not be needed in these patients. Please consult your doctor.
Emidas Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Emidas Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Emidas Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Esmatrix Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)